The findings of the HARMONi-2 trial could significantly change how NSCLC is treated, particularly if the promising results are validated in future studies. Here are the key points:
Trial Overview
The HARMONi-2 trial compared ivonescimab...
When you partner with Syenza, it’s like a Nuclear Fusion.
Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in
health policy, health economics, systems analysis, public finance, business, and project management.
You’ll also feel our high-impact global and local perspectives with cultural intelligence.